Mutant Prevention Concentrations of ABT-492, Levofloxacin, Moxifloxacin, and Gatifloxacin against Three Common Respiratory Pathogens

The purpose of this study was to compare the mutant prevention concentration (MPC) of ABT-492 to those of levofloxacin, moxifloxacin, and gatifloxacin against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. The fluoroquinolones had comparable mutation selection windows,...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Hermsen, Elizabeth D., Hovde, Laurie B., Konstantinides, George N., Rotschafer, John C.
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2005
Assuntos:
Susceptibility
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1068586/
https://ncbi.nlm.nih.gov/pubmed/15793158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.49.4.1633-1635.2005
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares